Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
Nutrien Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$49.51 |
52 Week High | CA$64.60 |
52 Week Low | CA$44.60 |
Beta | 0.97 |
1 Month Change | 3.04% |
3 Month Change | 6.70% |
1 Year Change | -23.36% |
3 Year Change | 10.69% |
5 Year Change | 2.92% |
Change since IPO | 24.30% |
Recent News & Updates
Recent updates
Shareholder Returns
N7T | DE Chemicals | DE Market | |
---|---|---|---|
7D | -1.5% | -1.4% | -2.0% |
1Y | -23.4% | -1.2% | -0.3% |
Return vs Industry: N7T underperformed the German Chemicals industry which returned -1.2% over the past year.
Return vs Market: N7T underperformed the German Market which returned -0.3% over the past year.
Price Volatility
N7T volatility | |
---|---|
N7T Average Weekly Movement | 4.4% |
Chemicals Industry Average Movement | 4.1% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.0% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: N7T has not had significant price volatility in the past 3 months.
Volatility Over Time: N7T's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 25,900 | Ken Seitz | www.nutrien.com |
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products.
Nutrien Ltd. Fundamentals Summary
N7T fundamental statistics | |
---|---|
Market cap | €24.59b |
Earnings (TTM) | €1.18b |
Revenue (TTM) | €26.36b |
20.6x
P/E Ratio0.9x
P/S RatioIs N7T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
N7T income statement (TTM) | |
---|---|
Revenue | US$28.08b |
Cost of Revenue | US$19.61b |
Gross Profit | US$8.47b |
Other Expenses | US$7.22b |
Earnings | US$1.26b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
Earnings per share (EPS) | 2.54 |
Gross Margin | 30.18% |
Net Profit Margin | 4.48% |
Debt/Equity Ratio | 44.6% |
How did N7T perform over the long term?
See historical performance and comparison